Le Lézard
Classified in: Science and technology, Covid-19 virus
Subjects: Photo/Multimedia, Conference, Event, Product/Service, Personnel

Dr. Sanjay Gupta Joins NIH and CDC Officials as well as Fortune 500 and International C-Level Business Executives Presenting at the Everbridge COVID-19 Road to Recovery (R2R) Virtual Summit, October 14-15, 2020


Everbridge, Inc. (NASDAQ: EVBG), the global leader in critical event management (CEM), today announced its Autumn 2020 "COVID-19 R2R: The Road to Recovery" virtual leadership summit to be held October 14-15, 2020. Following the success of its first summit earlier this year, attended by more than 10,000 global executives, COVID-19 R2R: The Road to Recovery will feature marquee keynotes from American physician, presidential advisor and Director of the National Institute of Allergy and Infectious Diseases (NIAID) at the U.S. National Institutes of Health (NIH) Dr. Anthony Fauci and renowned neurosurgeon and CNN Chief Medical Correspondent Dr. Sanjay Gupta. Doctors Fauci and Gupta join top Centers for Disease Control and Prevention (CDC) leaders, government officials and business executives in presenting at Everbridge's second virtual symposium dedicated to recovery in the face of the coronavirus pandemic. Additional keynote speakers, including a world leader, will be announced at a later date.

To register for this leadership event, please visit Everbridge's event registration page.

The two-day virtual summit will provide a global forum to discuss the response to the coronavirus pandemic; review success stories related to how business, healthcare and government leaders brought people back to work spaces, school and healthcare campuses, and public places; offer expert advice for restoring revenue-generating operations; and help attendees chart a productive way forward. The event will include an international segment focused on how multinational companies and governments around the world are meeting the challenges of the pandemic.

"Following the tremendous response to Everbridge's most recent COVID-19 ?Road to Recovery' summit in May, our Autumn 2020 symposium will provide C-level executives and other global leaders with an update on the world's COVID-19 response and offer actionable advice for mitigating the impact of the pandemic as we reopen our offices, schools and economies," said Everbridge Chief Executive Officer David Meredith.

Dr. Sanjay Gupta will kick off the event on October 14th. As a practicing neurosurgeon, Dr. Gupta reports on health and medical news for all of CNN's programs domestically and internationally, and regularly contributes to CNN.com. He received multiple Emmy® Awards for his reporting and Forbes Magazine named Dr. Gupta one of the "Ten Most Influential Celebrities." He also won several awards for his humanitarian efforts and the John F. Kennedy University Laureate award. Dr. Gupta received his undergraduate degree from the University of Michigan and a Doctorate of Medicine degree from the University of Michigan Medical School. He also received numerous honorary degrees.

The second day of the event, October 15th, will feature Anthony S. Fauci, M.D. Dr. Fauci is director of the National Institute of Allergy and Infectious Diseases (NIAID) at the U.S. National Institutes of Health (NIH), where he oversees an extensive research portfolio focused on infectious and immune-mediated diseases. As the long-time chief of the NIAID Laboratory of Immunoregulation, Dr. Fauci has made many seminal contributions in basic and clinical research and is one of the world's most-cited biomedical scientists. He was one of the principal architects of the President's Emergency Plan for AIDS Relief (PEPFAR), a program that has saved millions of lives throughout the developing world.

COVID-19 R2R: The Road to Recovery, Autumn 2020

The symposium will focus on the policies and actions organizations can take during the pandemic to keep people safe, execute contact tracing, return people to workplaces, campuses, and public spaces, protect supply chains, restore operations, and help organizations manage their reputations and communications to foster consumer safety and trust; all while managing across multiple critical events that could include hurricanes, wildfires, production stoppages, IT outages and cyberattacks.

Expected topics include:

Speakers representing the healthcare and government sectors include Roberta Levy Schwartz, Ph.D., FACHE, Chief Executive Officer, Executive Vice President and Chief Innovation Officer at Houston Methodist Hospital; Dr. Judy Monroe, Chief Executive Officer of the CDC Foundation; and Dr. Nancy Messonnier, Director of the Center for the National Center for Immunization and Respiratory Diseases (NCIRD).

Representative C-level speakers from the Fortune 500 and international corporations include Accenture's Arlin Pedrick, Capital One's William Baker, Humana's Stephan Pazienza, and Siemens' Marco Mille, among others.

To see a list of speakers and register for the event, please visit here. Several other additional speakers will be announced at a later date.

Everbridge hosted its most recent virtual symposium, "Coronavirus: The Road to Recovery," in May of this year, attracting more than 10,000 global executives from business, government, and healthcare. Keynote speakers included General Colin L. Powell USA (Ret.) and former Commissioner of the FDA Scott Gottlieb, MD, with presentations by senior executives from the NBA's Boston Celtics, Cleveland Clinic, U.S. Army, Fortune #124 Thermo Fisher Scientific, and the State of Florida, among many others. On-demand content from the first summit can be found here.

Over 5,300 global organizations use Everbridge's CEM Platform to assess threats, monitor the wellbeing of their workforce, rapidly communicate warnings, and protect supply chains. At the onset of the pandemic, Everbridge rapidly launched its COVID-19 Shieldtm Return to Work and Contact Tracing software solutions followed by the introduction of Everbridge Control Center, the industry's first off-the-shelf physical security information management software platform to help organizations return to work while complying with social distancing and Personal Protective Equipment (PPE) policies. Since the pandemic began, Everbridge customers have used its software to send more than 780 million coronavirus-related communications with vital information and instructions to safeguard their populations, employees, patients, and students.

Everbridge serves over 3,700 first responder agencies and 1,500 healthcare entities including the top pharmaceutical, biomedical and medical device and manufacturing companies, as well as the largest healthcare systems (overseeing more than 25 percent of all hospital beds in the U.S.), managed care organizations, pharmacies, and statewide health alert networks (HANs), including the CDC and the NIH.

The Everbridge Platform reaches over 600 million people and currently supports the countrywide public warning system deployments in all major regions of the world. Everbridge supports population-wide alerting in 11 countries across Europe, Asia, Oceania, The Middle East, Africa, and South America including Australia, Iceland, the Netherlands, New Zealand, Norway, Peru, Singapore and Sweden. Everbridge's population alerting capabilities also power the entire states of California, Massachusetts, Vermont, New York, Connecticut, and Florida, as well as municipalities, counties and cities within 49 of the 50 United States, within all of Canada's provinces, and throughout Europe and Asia, including deployments within multiple populous states in India.

About Everbridge

Everbridge, Inc. (NASDAQ: EVBG) is a global software company that provides enterprise software applications that automate and accelerate organizations' operational response to critical events in order Keep People Safe and Businesses Runningtm. During public safety threats such as active shooter situations, terrorist attacks or severe weather conditions, as well as critical business events including IT outages, cyber-attacks or other incidents such as product recalls or supply-chain interruptions, over 5,300 global customers rely on the Company's Critical Event Management Platform to quickly and reliably aggregate and assess threat data, locate people at risk and responders able to assist, automate the execution of pre-defined communications processes through the secure delivery to over 100 different communication devices, and track progress on executing response plans. Everbridge serves 8 of the 10 largest U.S. cities, 9 of the 10 largest U.S.-based investment banks, 47 of the 50 busiest North American airports, 9 of the 10 largest global consulting firms, 8 of the 10 largest global automakers, 9 of the 10 largest U.S.-based health care providers, and 7 of the 10 largest technology companies in the world. Everbridge is based in Boston with additional offices in 14 cities around the globe. For more information visit www.everbridge.com

Cautionary Language Concerning Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding the anticipated opportunity and trends for growth in our critical communications and enterprise safety applications and our overall business, our market opportunity, our expectations regarding sales of our products, our goal to maintain market leadership and extend the markets in which we compete for customers, and anticipated impact on financial results. These forward-looking statements are made as of the date of this press release and were based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Words such as "expect," "anticipate," "should," "believe," "target," "project," "goals," "estimate," "potential," "predict," "may," "will," "could," "intend," variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond our control. Our actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to: the ability of our products and services to perform as intended and meet our customers' expectations; our ability to successfully integrate businesses and assets that we may acquire; our ability to attract new customers and retain and increase sales to existing customers; our ability to increase sales of our Mass Notification application and/or ability to increase sales of our other applications; developments in the market for targeted and contextually relevant critical communications or the associated regulatory environment; our estimates of market opportunity and forecasts of market growth may prove to be inaccurate; we have not been profitable on a consistent basis historically and may not achieve or maintain profitability in the future; the lengthy and unpredictable sales cycles for new customers; nature of our business exposes us to inherent liability risks; our ability to attract, integrate and retain qualified personnel; our ability to maintain successful relationships with our channel partners and technology partners; our ability to manage our growth effectively; our ability to respond to competitive pressures; potential liability related to privacy and security of personally identifiable information; our ability to protect our intellectual property rights, and the other risks detailed in our risk factors discussed in filings with the U.S. Securities and Exchange Commission ("SEC"), including but not limited to our Annual Report on Form 10-K for the year ended December 31, 2019 filed with the SEC on February 28, 2020. The forward-looking statements included in this press release represent our views as of the date of this press release. We undertake no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.

All Everbridge products are trademarks of Everbridge, Inc. in the USA and other countries. All other product or company names mentioned are the property of their respective owners.


These press releases may also interest you

at 00:30
Frost & Sullivan recently researched the data center colocation services industry and, based on its findings, recognizes STT GDC India with the 2023 Indian Company of the Year Award. STT GDC India is a pioneer data center solutions provider that...

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

at 00:24
In the news release, Roborock Reports 2023 Full Year Financial Results, issued 28-Mar-2024 by Roborock over PR Newswire, we are advised by the company that in the first bullet point of "Growth across Product Categories", the USD amount should read...

28 mar 2024
The opening ceremony of the Boao Forum for Asia (BFA) Annual Conference 2024 was held in Boao, south China's Hainan Province on Thursday, with China's top legislator Zhao Leji stressing China's economic potential, appealing to international investors...

28 mar 2024
OKX Ventures, the investment arm of leading Web3 technology company OKX, has issued updates for March 29, 2024. OKX Ventures...

28 mar 2024
Curio Legacy Ventures (Curio), a frontrunner in nuclear technology innovation, proudly announces a strategic partnership with Navarro Research and Engineering, Inc. (Navarro). This collaboration signals a significant step forward in advancing nuclear...



News published on and distributed by: